Pfizer recently announced it would increase the U.S. list price of its patented Covid treatment nirmatrelvir-ritonavir (Paxlovid) to $1,390 for a five-day treatment course. Experts at Harvard University have estimated that the cost of producing a five-day course of nirmatrelvir-ritonavir is $13. Pub...